Dr Art Walaszek joins Ethics Talk to discuss his article, coauthored with Drs William Smith and David Elkin: “How to Draw on Narrative to Mitigate Ageism.”
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.
A physician argues against the use of placebo medications in routine clinical care situations where the medication may be warranted but the patient has not been fully informed about the treatment.